Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 33, 2009, Pages 14004-14009

  Lehmann, Steffi ^a   Stiehl, Daniel P ^a   Honer, Michael ^b   Dominietto, Marco ^a   Keist, Ruth ^a   Kotevic, Ivana ^a   Wollenick, Kristin ^a   Ametamey, Simon ^b   Wenger, Roland H ^a   Rudin, Markus ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Bioluminescence; Hypoxia inducible factor; Positron emission tomography; Reporter gene; Tumor allograft model

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CANCER CELL; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HYPOXIA; IMAGING SYSTEM; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; TUMOR GROWTH;

ANIMALS; ANOXIA; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUCIFERASES; MICE; MISONIDAZOLE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; POSITRON-EMISSION TOMOGRAPHY; RESPONSE ELEMENTS; TIME FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 69549138474     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0901194106     Document Type: Article

References (27)

1. Vaupel P (2004) Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14:198-206.
2. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551-578.
3. Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signaling in cancer and approaches to enforce tumor regression. Nature 441:437-443. (Pubitemid 44050138)
4. Unruh A, et al. (2003) The hypoxia-inducible factor-1 α is a negative factor for tumor therapy. Oncogene 22:3213-3220. (Pubitemid 36712933)
5. Wirthner R, et al. (2008) Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1α-deficient mouse embryonic fibroblasts. Carcinogenesis 29:2306-2316.
6. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732.
7. Coleman ML, Ratcliffe PJ (2007) Oxygen sensing and hypoxia-induced responses. Essays Biochem 43:1-15.
8. Corbett TH, et al. (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35:2434-2439.
9. Koh WJ, et al. (1992) Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 22:199-212.
10. 2-regulated prolyl hydroxylation. Science 292:468-472.
11. Raleigh JA, et al. (1998) Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 58:3765-3768. (Pubitemid 28405626)
12. Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia and cancer. J Mol Med 85:1301-1307.
13. DeYoung BR, et al. (1995) CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: Report of 145 cases and review of putative immunohistologic markers of endothelial differentiation. J Cutan Pathol 22:215-222.
14. Stiehl DP, et al. (2006) Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels: Evidence for an autoregulatory oxygen-sensing system. J Biol Chem 281:23482-23491.
15. Semenza GL (2002) HIF-1 and tumor progression: Pathophysiology and therapeutics. Trends Mol Med 8:62-67.
16. Mayer A, Hockel M, Wree A, Vaupel P (2005) Microregional expression of glucose transporter-1 and oxygenation status: Lack of correlation in locally advanced cervical cancers. Clin Cancer Res 11:2768-2773. (Pubitemid 40569479)
17. Mayer A, et al. (2004) Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res 64:5876-5881. (Pubitemid 39095589)
18. Vordermark D, Brown JM (2003) Evaluation of hypoxia-inducible factor-1α (HIF-1α) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: In vitro and xenograft studies. Int J Radiat Oncol Biol Phys 56:1184-1193. (Pubitemid 36794054)
19. Ljungkvist ASE, et al. (2000) Changes in tumor hypoxia measured with a double hypoxic marker technique. Int J Radiat Oncol Biol Phys 48:1529-1538.
20. Cardenas-Navia LI, et al. (2008) The pervasive presence of fluctuating oxygenation in tumors. Cancer Res 68:5812-5819.
21. Aprelikova O, et al. (2004) Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem 92:491-501.
22. Metzen E, et al. (2005) Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: Identification of a functional hypoxia-responsive element. Biochem J 387:711-717. (Pubitemid 40685705)
23. Wanner RM, et al. (2000) Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation. Blood 96:1558-1565.
24. Rolfs A, Kvietikova I, Gassmann M, Wenger RH (1997) Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J Biol Chem 272:20055-20062. (Pubitemid 27340110)
25. Lim JL, Berridge MS (1993) An efficient radiosynthesis of [18F]fluoromisonidazole. Appl Radiat Isot 44:1085-1091.
26. Missimer J, et al. (2004) Performance evaluation of the 16-module quad-HIDAC small animal PET camera. Phys Med Biol 49:2069-2081. (Pubitemid 38735492)
27. Honer M, et al. (2004) Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET. J Nucl Med 45:464-470. (Pubitemid 47618622)